Preferred Label : hydroquinidine;
MeSH note : urinary quinine metabolite; RN given refers to (9S)-isomer; structure in Merck Index,
9th ed, #4703;
CISMeF synonym : LCN 834; lentoquine; sanofi synthelabo brand of hydroquinidine hydrochloride; hydroquinine; sérécor;
MeSH synonym : dihydroquinidine;
MeSH hyponym : LCN-834;
Related MeSH term : dihydroquinine;
MeSH Related Number : hydroquinidine hydrochloride; hydroquinidine, (1beta,4beta,9S)-( -)-isomer; hydroquinidine, (8alpha,9R)-isomer; hydroquinidine, (8alpha,9S)-isomer; hydroquinidine, (3alpha,9S)-( -)-isomer; hydroquinidine, (9R)-isomer; hydroquinidine, (9S)-( -)-isomer; hydroquinidine dihydrochloride, (1beta,4beta,3S)-( -)-isomer; hydroquinidine dihydrochloride, (3alpha,9S)-( -)-isomer; hydroquinidine monosulfate; hydroquinidine monosulfate, (1beta,3alpha,4beta,8alpha,9R)-isomer; hydroquinidine monosulfate, (1beta,3alpha,4beta,9S)-isomer; hydroquinidine sulfate; hydroquinidine sulfate, (9S)-isomer; hydroquinidine, ( -)-isomer; hydroquinidine, (1beta, 3alpha,4beta,8alpha,9R)-isomer; hydroquinidine, (1beta,3alpha,4beta,9S)-isomer; 14645-32-0 ((9R)-isomer); 1476-98-8 ((S) isomer mono-HCl); 1668-97-9 ((8 alpha, 9R) mono-HCl); 23495-98-9 (( -)-isomer); 26666-96-6 ((9S)-( -)-isomer); 26666-97-7 (monosulfate( -)-isomer); 26852-57-3 (monosulfate); 35251-69-5 (monosulfate(1beta,3alpha,4beta,9S)-isomer); 35251-71-9 (monosulfate(1beta,3alpha,4beta,8alpha,9R)-isomer); 40542-76-5 (di-HCl(1beta,4beta,3S)-( -)-isomer); 40542-78-7 (di-HCl(3alpha,9S)-( -)-isomer); 47342-32-5 ((1beta, 3alpha,4beta,8alpha,9R)-isomer); 47342-33-6 ((1beta,3alpha,4beta,9S)-isomer); 51049-33-3 ((3alpha,9S)-( -)-isomer); 51049-34-4 ((1beta,4beta,9S)-( -)-isomer); 51743-68-1 ((8alpha,9S)-isomer); 522-66-7 ((8alpha,9R)-isomer); 57863-85-1 (sulfate(9S)-isomer); 57863-89-5 (sulfate); 6BR4G8VAHM; 1435-55-8 (hydroquinidine); 31J3Q51T6L;
Registry Number MeSH : 1435-55-8;
Related CAS MeSH : 51049-33-3 (hydroquinidine, (3alpha,9S)-( -)-isomer); 14645-32-0 (hydroquinidine, (9R)-isomer); 26666-96-6 (hydroquinidine, (9S)-( -)-isomer); 40542-76-5 (hydroquinidine dihydrochloride, (1beta,4beta,3S)-( -)-isomer); 40542-78-7 (hydroquinidine dihydrochloride, (3alpha,9S)-( -)-isomer); 26852-57-3 (hydroquinidine monosulfate); 35251-71-9 (hydroquinidine monosulfate, (1beta,3alpha,4beta,8alpha,9R)-isomer); 35251-69-5 (hydroquinidine monosulfate, (1beta,3alpha,4beta,9S)-isomer); 57863-89-5 (hydroquinidine sulfate); 57863-85-1 (hydroquinidine sulfate, (9S)-isomer); 23495-98-9 (hydroquinidine, ( -)-isomer); 47342-32-5 (hydroquinidine, (1beta, 3alpha,4beta,8alpha,9R)-isomer); 47342-33-6 (hydroquinidine, (1beta,3alpha,4beta,9S)-isomer); 51049-34-4 (hydroquinidine, (1beta,4beta,9S)-( -)-isomer); 522-66-7 (hydroquinidine, (8alpha,9R)-isomer); 51743-68-1 (hydroquinidine, (8alpha,9S)-isomer); 6BR4G8VAHM (hydroquinidine hydrochloride);
related registry number list (CISMeF) : 14645-32-0 ((9R)-isomer); 1476-98-8 ((S) isomer mono-HCl); 1668-97-9 ((8 alpha, 9R)
mono-HCl); 23495-98-9 (( -)-isomer); 26666-96-6 ((9S)-( -)-isomer); 26666-97-7 (monosulfate(
-)-isomer); 26852-57-3 (monosulfate); 35251-69-5 (monosulfate(1beta,3alpha,4beta,9S)-isomer);
35251-71-9 (monosulfate(1beta,3alpha,4beta,8alpha,9R)-isomer); 40542-76-5 (di-HCl(1beta,4beta,3S)-(
-)-isomer); 40542-78-7 (di-HCl(3alpha,9S)-( -)-isomer); 47342-32-5 ((1beta, 3alpha,4beta,8alpha,9R)-isomer);
47342-33-6 ((1beta,3alpha,4beta,9S)-isomer); 51049-33-3 ((3alpha,9S)-( -)-isomer);
51049-34-4 ((1beta,4beta,9S)-( -)-isomer); 51743-68-1 ((8alpha,9S)-isomer); 522-66-7
((8alpha,9R)-isomer); 57863-85-1 (sulfate(9S)-isomer); 57863-89-5 (sulfate);
Codes EINECS : 215-862-5;
Is substance : O;
UNII : 8P68XPY4HG;
Origin ID : C014486;
UMLS CUI : C0063103;
ATC code(s)
- CISMeF manual mappings
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3210097/fr/serecor
2020
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
hydroquinidine
hydroquinidine hydrochloride
anti-arrhythmia agents
brugada syndrome
arrhythmias, cardiac
recurrence
hydroquinidine
quinidine
quinidine
---
http://www.meddispar.fr/Medicaments/SERECOR-300-B-20/(type)/letter/(value)/S/(cip)/3400932400706
http://www.meddispar.fr/Medicaments/SERECOR-300-B-60/(type)/letter/(value)/S/(cip)/3400932400874
2013
false
France
French
hydroquinidine
drug information
administration, oral
Delayed-Action preparations
drug prescriptions
legislation, drug
quinidine
hydroquinidine hydrochloride
hydroquinidine
---
http://www.has-sante.fr/portail/display.jsp?id=c_632378
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4954_serecor.pdf
2008
false
France
French
secondary prevention
hydroquinidine
capsules
quinidine
insurance, health, reimbursement
tachycardia, supraventricular
arrhythmias, cardiac
ventricular arrhythmia, nos
hydroquinidine
anti-arrhythmia agents
administration, oral
Delayed-Action preparations
evaluation of the transparency committee
---
